Oragenics (OGEN) said Tuesday it priced a public offering of up to 800,000 shares of series H convertible preferred stock, each bundled with a warrant to purchase an additional preferred share, at a combined price of $25 per unit, for potential gross proceeds of up to $20 million.
Shares sank 58% following an increase in intraday trading volume to over 14.2 million from a daily average of about 228,000.
Cellectar Biosciences (CLRB) said Tuesday it priced an underwritten offering of shares and warrants, targeting roughly $6 million in gross proceeds.
Shares plunged 30% as intraday trading volume rose to over 744,000 from a daily average of about 429,000.
Webus International (WETO) shares fell 14% after the company said it signed a conditional securities purchase agreement with Ripple Strategy for a senior equity line of credit of up to $100 million.
More than 42.4 million shares traded intraday compared with a daily average of about 722,000.
Price: 1.60, Change: -2.22, Percent Change: -58.22
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.